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ARTICLE
Shear-induced Notch-Cx37-p27 axis arrests
endothelial cell cycle to enable arterial speciﬁcation
Jennifer S. Fang1,2,3,4, Brian G. Coon 1,2,3, Noelle Gillis1,2,3,4, Zehua Chen5, Jingyao Qiu1,2,3,4,6,
Thomas W. Chittenden5,7,8, Janis M. Burt9, Martin A. Schwartz 1,2,3,10,11 & Karen K. Hirschi 1,2,3,4,6,11
Establishment of a functional vascular network is rate-limiting in embryonic development,
tissue repair and engineering. During blood vessel formation, newly generated endothelial
cells rapidly expand into primitive plexi that undergo vascular remodeling into circulatory
networks, requiring coordinated growth inhibition and arterial-venous speciﬁcation. Whether
the mechanisms controlling endothelial cell cycle arrest and acquisition of specialized phe-
notypes are interdependent is unknown. Here we demonstrate that ﬂuid shear stress, at
arterial ﬂow magnitudes, maximally activates NOTCH signaling, which upregulates GJA4
(commonly, Cx37) and downstream cell cycle inhibitor CDKN1B (p27). Blockade of any of
these steps causes hyperproliferation and loss of arterial speciﬁcation. Re-expression of GJA4
or CDKN1B, or chemical cell cycle inhibition, restores endothelial growth control and arterial
gene expression. Thus, we elucidate a mechanochemical pathway in which arterial shear
activates a NOTCH-GJA4-CDKN1B axis that promotes endothelial cell cycle arrest to enable
arterial gene expression. These insights will guide vascular regeneration and engineering.
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Establishment of a well-organized and perfused circulatorysystem is essential to oxygenate tissues and remove meta-bolic waste. When new blood vessels form, during devel-
opment or in response to tissue injury, newly generated
endothelial cells rapidly proliferate and coalesce into disorganized
capillary plexi. Coincident with the onset of blood ﬂow through
vessel lumens, endothelial cell proliferation is reduced and pri-
mitive vessels remodel into arterial-venous networks that acquire
mural cell coverage (reviewed in Ribatti et al.1). Although we have
made progress in identifying factors that stimulate endothelial cell
proliferation and sprouting (reviewed in Marcelo 2013a2), limited
understanding of the regulation of endothelial cell growth sup-
pression and phenotypic specialization during vascular remo-
deling remains a signiﬁcant roadblock for clinical therapies, tissue
engineering and regenerative medicine.
Fluid shear stress (FSS) likely guides vascular remodeling to
maximize efﬁcient tissue perfusion (reviewed in Baeyens and
Schwartz, 20153), but underlying mechanisms are poorly under-
stood. Interestingly, both ﬂow-induced mechanotransduction4–10
and NOTCH signaling11–15 are implicated in endothelial growth
control and arterial development; however, whether these path-
ways coordinately regulate these processes, and whether
endothelial cell growth arrest is required for arterial-venous
speciﬁcation, require further study.
We recently found that endothelial cells require NOTCH-
induced cell cycle arrest via regulation of CDKN1B (commonly,
p27) for acquisition of a hemogenic phenotype that enables
blood-forming potential16. Since NOTCH is also implicated in
arterial11, as well as lymphatic17, endothelial cell development, we
considered whether NOTCH might play a common role in these
processes. That is, perhaps NOTCH-induced cell cycle arrest is
required for endothelial cells to acquire all of these specialized
phenotypes and functions. Indeed, cell cycle state of undiffer-
entiated embryonic stem cells strongly inﬂuences cell fate deci-
sions18, but it is unclear whether a similar mechanism applies to
endothelial cell speciﬁcation. We, therefore, investigated whether
NOTCH signaling mediates ﬂow-induced endothelial cell growth
control, and whether endothelial cell cycle state determines their
propensity to acquire an arterial identity.
Examining both post-natal retina neovascularization and cul-
tured endothelial cells, we deﬁne a novel signaling pathway
whereby FSS, at arterial magnitudes, maximally activates NOTCH
signaling, which upregulates GJA4, more commonly known as
Connexin37 (Cx37), and downstream CDKN1B to promote
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Fig. 1 NOTCH signaling regulates shear-induced endothelial cell quiescence. a Expression of several NOTCH signaling pathway effectors were signiﬁcantly
altered in whole-transcriptome analysis of HUVEC exposed to 6 h FSS (vs. 6 h Static), as were previously characterized ﬂow-responsive genes KLF2, KLF4,
and COX. b Cleavage of NOTCH receptor intracellular domain (NICD) was signiﬁcantly increased with 1 h of 12 dynes/cm2 FSS (mean densitometry± SEM;
n= 3 for all groups; Students’ t-test: p= 0.03), and blocked by 10 µM DAPT. Uncropped blots presented in Supplementary Fig. 1. c HEY1 and HEY2
transcript levels were elevated with 16 h FSS (mean relative mRNA expression± SEM vs. Static; n= 3 for all groups; Students’ t-test: p= 0.003 (HEY1), p=
0.005 (HEY2)). d EdU incorporation, a measure of DNA synthesis and indicator of proliferation, was reduced over 18 h exposure to FSS in control cells, and
this response was abrogated by inhibition of NOTCH signaling (via 10 µM DAPT) (Colors: Hoechst (cyan), EdU (green); scale bar= 100 µm; mean % EdU-
positive nuclei± SEM for 8 ROI; representative of n= 3 experiments; Students’ t-test: p= 0.09 (12 h), p= 0.0006 (18 h))
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endothelial G1 arrest and to enable expression of arterial genes.
This link between endothelial cell cycle and cell fate was not
previously known, and is critically important for controlling
blood vessel development and remodeling. Insights gained from
these studies will facilitate efforts to optimize vascular regenera-
tion of injured and diseased tissues in vivo and blood vessel
engineering ex vivo.
Results
Flow-dependent endothelial quiescence is mediated by
NOTCH. Preliminary experiments conﬁrmed that physiological
FSS (12 dynes/cm2) suppressed the incorporation of EdU, a
measure of DNA synthesis and indicator of proliferation, in
human umbilical vein endothelial cells (HUVEC) at 12–24 h. To
identify mediators of ﬂow-dependent endothelial cell quiescence,
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Fig. 2 Shear-sensitive NOTCH upregulates GJA4 expression. a Exposure of HUVEC to 6 h FSS signiﬁcantly upregulated GJA4 protein, in parallel with
sustained increase in NICD (mean densitometry± SEM; n= 5 (Static, 3 h FSS), n= 4 (6 h FSS); one-way ANOVA: p= 0.04 (NICD), p= 0.004 (GJA4),
asterisks indicate p< 0.05 in post hoc t-test vs. Static). Uncropped blots presented in Supplementary Fig. 3. b si-GJA4 and DAPT (alone or in combination)
abrogated ﬂow-induced suppression of EdU incorporation at 12–18 h shear (mean % EdU-positive nuclei± SEM for 8 ROI; representative of n= 3
experiments; one-way ANOVA: p< 0.0001 (12 h FSS, 18 h FSS), asterisks indicate p< 0.05 in post hoc t-test). c GJA4 levels were reduced by treatment of
conﬂuent HUVEC with 8 h or 24 h DAPT (mean relative mRNA expression± SEM vs. DMSO; n= 3 (8 h), n= 5 (24 h); individual values plotted where n<
5; Students’ t-test: p= 0.01 (8 h), p= 0.006 (24 h)). d 24 h DAPT also reduced GJA4 protein levels in conﬂuent HUVEC. Uncropped blots presented in
Supplementary Fig. 3. e Seeding of sub-conﬂuent HUVEC onto recombinant DLL4 increased GJA4 mRNA levels (mean relative mRNA expression± SEM
vs. PBS; n= 5 for all groups; Students’ t-test: p= 0.03 (3 h), p= 0.002 (6 h), p< 0.0001 (9 h)). f GJA4 protein and NICD were increased following seeding
of sub-conﬂuent HUVEC onto Dll4 for 8 h. Uncropped blots presented in Supplementary Fig. 3. g Signiﬁcant GJA4 promoter fold enrichment was detected
in samples assayed by ChIP using anti-RBP-Jκ, compared to IgG controls. This effect was abolished with DAPT treatment (mean fold enrichment± SEM vs
IgG; n= 3 for all groups; Students t-test: p= 0.007 (anti-RBP-Jκ)). h si-NOTCH1, but not si-NOTCH4, abolished DLL4-induced upregulation of GJA4 mRNA
at 6 h following cell seeding (mean relative mRNA expression± SEM vs. PBS; n= 7 (si-Ctrl, si-NOTCH1), n= 8 (si-Ctrl, si-NOTCH4); Students’ t-test: p<
0.0001 (si-Ctrl), p= 0.02 (si-NOTCH4))
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we performed whole-transcriptome sequencing (RNA-seq) on
HUVEC under static or FSS conditions for 6 h, a time likely to
reveal cell signaling pathways that mediate cell cycle arrest fol-
lowing onset of shear. FSS altered the expression of 6,512 genes.
Gene ontology (GO) and nested gene ontology (nGO) analyses
designed to control for gene length bias were used to assess
functional enrichment of altered genes, and a subset of GO-nGO
pairs were selected for overlapping relevance to cell proliferation,
cell signaling and development (Supplementary Data 1). NOTCH
signaling was the top candidate pathway within this subset
(Supplementary Table 1). Several NOTCH-associated genes,
including ligands DLL1, DLL4, JAG1, and JAG2, and canonical
NOTCH transcriptional targets HES1, HES2, HEY1, and HEY2,
were altered by shear (Fig. 1a). Interestingly, mRNA levels for
endothelial-expressed receptors NOTCH1 and NOTCH4 were not
affected by FSS. Activation of shear-dependent signaling was
conﬁrmed by strong upregulation of KLF2, KLF4, and COX
genes.
To verify that ﬂow induces NOTCH signaling, HUVEC were
exposed to shear. Cleavage of the NOTCH intracellular domain
(NICD), which mediates gene transcription upon receptor
activation, was increased with 1 h FSS and blocked by pre-
treatment with 10 µM DAPT, a pharmacological inhibitor of
NOTCH cleavage and signaling (Fig. 1b and Supplementary
Fig. 1). In addition, NOTCH target genes HEY1 and HEY2 were
signiﬁcantly upregulated by 16 h of FSS (Fig. 1c). Inhibiting
NICD cleavage with 10 µM DAPT also signiﬁcantly alleviated
FSS-mediated suppression of endothelial cell EdU incorporation
(Fig. 1d). Altogether, these data show that NOTCH signaling
mediates shear-induced endothelial cell growth suppression.
GJA4 mediates endothelial quiescence downstream of NOTCH.
To identify genes regulated by NOTCH under ﬂow, RNA-seq was
performed on HUVEC exposed to 6 h of FSS with or without 10
µM DAPT. Of the top ﬁve genes, only GJA4 (which encodes
GJA4, more commonly known as Connexin37, or Cx37) and
TMEM100 (which encodes Transmembrane Protein 100) were
both upregulated by shear and suppressed in the presence of
DAPT (Supplementary Table 2 and Supplementary Fig. 2). Of
these, GJA4 was selected for further study because of its
endothelial-speciﬁc expression during development19, and in vivo
evidence of its involvement in blood20,21 and lymphatic17,22–24
vascular morphogenesis. We found that GJA4 protein was ele-
vated after 6 h FSS in association with sustained upregulation of
NICD (Fig. 2a and Supplementary Fig. 3). GJA4 knockdown (si-
GJA4, validated in Supplementary Fig. 4) impaired shear-induced
suppression of cell proliferation, as did DAPT (si-Ctrl+DAPT),
while si-GJA4 combined with DAPT had no additional effects
(Fig. 2b). Altogether, these data suggest that GJA4 is the pre-
dominant mediator of NOTCH- and ﬂow-induced endothelial
cell growth arrest.
NOTCH signaling regulates GJA4 expression. To determine
whether NOTCH regulates GJA4, we used conﬂuent endothelial
cell monolayers as a convenient system, in which there is basal
activation of NOTCH through ligand–receptor interactions. As
expected, endothelial cells exhibited density-dependent NOTCH
activation, which was suppressed by DAPT inhibition of NICD
cleavage (Supplementary Fig. 5), resulting in decreased endo-
genous HES1 mRNA levels (Supplementary Fig. 6A). DAPT
treatment of conﬂuent endothelial cells also reduced mRNA and
protein levels for GJA4 (Fig. 2c, d and Supplementary Fig. 3).
Basal NOTCH signaling was undetectable in sub-conﬂuent
HUVEC (Supplementary Fig. 5), but induced by seeding sub-
conﬂuent cells onto immobilized recombinant DLL4 ligand to
constitutively activate NOTCH leading to upregulation of HES1
mRNA (Supplementary Fig. 4B). Seeding of sub-conﬂuent
HUVEC onto recombinant DLL4 also upregulated GJA4 mRNA
and protein, along with increased NICD (Fig. 2e, f).
NOTCH stimulates transcription of target genes through
binding of cleaved NICD to a nuclear gene regulatory complex
that includes the DNA-binding protein RBP-Jκ. In silico analysis
revealed several high-probability RBP-Jκ binding motifs in the
regulatory regions of the mouse and human GJA4 genes including
several motifs adjacent to the transcriptional start site (Supple-
mentary Table 3). To determine whether GJA4 is a direct target of
the NICD-RBP-Jκ complex, we performed chromatin-
immunoprecipitation (ChIP) on conﬂuent HUVEC monolayers
(in which NOTCH is basally active, Supplementary Fig. 5).
Immunoprecipitates of RBP-Jκ from these cells revealed enrich-
ment of the GJA4 promoter region relative to the IgG control,
which was blocked by DAPT (Fig. 2g). Thus, GJA4 appears to be
a transcriptional target of NICD/RBP-Jκ.
Endothelial cells express two NOTCH receptors, NOTCH1 and
NOTCH4, both capable of inducing canonical NOTCH signaling
and downstream transcriptional activation. Expression of each
NOTCH receptor was selectively reduced by siRNA against
NOTCH1 or NOTCH4, respectively (Supplementary Fig. 6C).
Knockdown of either NOTCH1 or NOTCH4 abolished DLL4-
induced upregulation of HES1 (Supplementary Fig. 6D); however,
only si-NOTCH1, and not si-NOTCH4, eliminated DLL4-induced
upregulation of GJA4 mRNA (Fig. 2h), suggesting that GJA4
expression is speciﬁcally regulated by NOTCH1.
GJA4 is expressed in remodeling blood vessel endothelium. To
examine the role of GJA4 in vascular remodeling in vivo, we
used the well-studied neonatal murine retinal vascularization
model12,25–27. Beginning at post-natal day 1 (P1), rapid, highly
stereotyped vascularization initiated from a central vascular
plexus can be visualized over subsequent days by labeling endo-
thelial cells using either antibodies targeting PECAM1
(or, CD31) or with ﬂuorescently conjugated isolectin B4 (IB4).
(Supplementary Fig. 7A). Over subsequent days, endothelial cells
at the retinal vascular edge proliferate and migrate radially out-
ward, while nascent blood vessels interior from the vascular front
remodel, mature and recruit smooth muscle actin (SMA)-positive
mural cells to form a functional circulatory network. At P6, the
developing retinal vasculature includes an outer region of active
vessel remodeling (R) and a more central region with mature (M),
speciﬁed arteries and veins. For our studies, we designated the
R–M boundary (dashed yellow line) as the distance of SMA
investment of arteries, (Supplementary Fig. 7B), which was 519±
64μm (n= 6, multiple litters) from the vascular front at P6.
Intracardiac injection of rhodamine dextran revealed that vessels
of the remodeling plexus were lumenized and were accessible to
systemic blood ﬂow (Supplementary Fig. 7C). This ﬁnding was
consistent with in silico models of retinal blood ﬂow, which show
that the remodeling plexi experience near-arterial levels of shear
stress28. In addition, activated ERK5 (pERK5), which is acutely
induced by ﬂow in endothelial cells in culture29, was abundant in
remodeling retinal vessels (Supplementary Fig. 7D).
In wild-type (WT) P6 mice, GJA4 was expressed in endothelial
cells of the remodeling vessel plexus and in associated maturing
arteries (Fig. 3a, b), but not at the vascular edge (Fig. 3c) where
FSS is limited28 and where endothelial cells are highly
proliferative13. In adult tissues, GJA4 is typically observed co-
expressed with GJA5 (commonly, Connexin40 or Cx40) in large
arteries;30,31 however, in the developing neonatal mouse retina,
GJA5 was restricted to SMA-positive arteries (Supplementary
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Fig. 8), and not detected in remodeling vessels at the R–M
boundary where GJA4 was highly expressed (Fig. 3b).
Loss of GJA4 or NOTCH signaling causes remodeling defects.
GJA4 is implicated in blood vessel formation, as mice deﬁcient in
GJA4 exhibit increased tissue vascularization[20], enhanced
neovascularization of injured tissues20,32, and dysregulation of
venous valve formation21. However, developmental blood vessel
formation has not been well studied in these mice. We therefore
examined vascularization of Gja4−/−, Gja4+/−, and Gja4+/+
(WT) neonatal retinas. Vascular morphology was similar between
Gja4+/− and age-matched Gja4+/+ controls (Supplementary
Fig. 9A–C). However, Gja4−/− retinal vascular plexi were
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hyperdense and poorly remodeled (Fig. 3d) compared to age-
matched Gja4+/+ controls, and there was a ~25% increase in
vascular area and vessel branchpoint number within the remo-
deling zone of Gja4−/− mice (Fig. 3f–g). Hyperdensity was
observed in nearly 80% of imaged remodeling plexi from Gja4−/−
retinas, indicating high penetrance of this phenotype (Supple-
mentary Fig. 9D). Consistent with the absence of detectible GJA4
in endothelial cells at the vascular edge, GJA4 deletion had no
effect on tip cell number (Supplementary Fig. 10).
The Gja4−/− phenotype resembles the hyperdense vasculature
observed with disrupted NOTCH signaling12,25, such as with
DAPT treatment of WT mice or with tamoxifen-induced
endothelial-speciﬁc deletion of NOTCH1 (Notch1iECKO) (Fig. 3d).
Pharmacological inhibition of endothelial NOTCH signaling via
24 h DAPT was conﬁrmed by observation of a ~50% decrease in
expression of canonical NOTCH target genes (Hes1, Hey1 and
Hey2) in retinal endothelial cells (Fig. 3e). Like Gja4−/− animals,
DAPT-treated WT and Notch1iECKO-Cre+ animals experienced a
~25% increase in vascular area and branchpoint number in the
remodeling zone (Fig. 3f, g) compared to associated controls.
However, unlike with GJA4 deletion, NOTCH inhibition (via
DAPT) uniquely increased tip cell number (Supplementary
Fig. 10), suggesting that GJA4 mediates distinct NOTCH effects
in the remodeling vasculature. Consistent with this, GJA4
expression was greatly reduced in remodeling vessels of both
DAPT-treated WT and Notch1iECKO retinas (Fig. 3h).
To determine whether Gja4−/− retinas exhibited vascular
morphology defects at later stages of development, we assessed
the retinal vasculature at P21, at which time the superﬁcial
vascular plexus established in P3-9 (Supplementary Fig. 7A) has
undergone additional remodeling and regression to form a
mature network. Meanwhile, smaller vessels have sprouted from
the superﬁcial vasculature beginning at P10, and have invaded
downward to form a secondary deep vascular plexus below the
superﬁcial network. Consistent with our observations at P6, we
observed a signiﬁcant increase in vascular area in the deep
vascular plexus of Gja4−/− mice compared to Gja4+/− littermates
(Supplementary Fig. 11A). In addition, we observed a signiﬁcant
increase in the number of arterial branches in the superﬁcial
plexus of Gja4−/− compared to littermate controls (Supplemen-
tary Fig. 11B) even though overall vascular area was not
measurably different at this stage (Supplementary Fig. 11A).
These data suggest that while many of the vessels of the
hyperdense Gja4−/− remodeling plexus (Fig. 3d) may eventually
regress, Gja4−/− animals retain a vascular hyperbranching
phenotype in the mature retinal circulation, which is consistent
with our previous observations of excessive collateral connections
in the pial circulation and increased hindlimb vascularization in
response to ischemic damage20,32.
NOTCH suppresses endothelial cell proliferation via GJA4.
The hyperdense phenotype of the NOTCH-inhibited and Gja4−/−
P6 retinal vasculature (Fig. 3) suggested altered endothelial cell
proliferation. Using ﬂuorescence-activated cell sorting (FACS),
we isolated retinal endothelial cells (CD31+/CD45−) from WT
(Gja4+/+), Gja4−/− and WT+DAPT P6 mice, and examined their
cell cycle distribution. WT P6 retinal endothelial cells had the
following cell cycle distribution: 27.0± 2.6% in G0, 50.6± 2.8% in
G1 and 22.4± 2.5 % in S/G2/M. Both WT+DAPT and Gja4−/−
retinas appeared to have fewer endothelial cells in G0 and G1
phases, and in both groups a signiﬁcantly increased proportion of
actively cycling (S/G2/M) cells were observed (Fig. 4a). We
further conﬁrmed an increase in endothelial cell proliferation
using the mitotic marker phospho-HIST3 (pH3), in conjunction
with endothelial nuclear marker (ERG) (Fig. 4b, images).
We found increased numbers of pH3+ endothelial cell nuclei
(pH3+ /ERG+ ) in the remodeling plexi of Gja4−/− and WT
+DAPT retinas (Fig. 4b, graph). Finally, when Gja4−/− mutants
were crossed with Cdt1-mOrange+ reporter mice, in which cells
in G1 phase of the cell cycle express CDT1-mOrange fusion
protein, Gja4−/− remodeling retinal vascular plexi had fewer
endothelial cells in G1 phase, consistent with dysregulation of cell
cycle arrest (Fig. 4c).
Next, we assessed whether GJA4 was responsible for the effects
of NOTCH on endothelial cell cycle status. We transfected
HUVEC with full-length mouse Gja4 (lenti-Gja433) to constitu-
tively express GJA4 (or with lenti-Ctrl for control cells). As
previously described33, lenti-Gja4 effectively induced normal
levels of GJA4 protein, which properly localized to cell-cell
junctions (Supplementary Fig. 12A). Cells were then treated for
24 h with 10 µM DAPT, which we previously showed effectively
blocks NOTCH signaling (Figs. 1, 2 and Supplementary Fig. 6),
and cell cycle distribution was assessed. Control (DMSO-treated)
cells had the following cell cycle distribution: 27.8± 4.9% in G0,
52.5± 3.8% in G1 and 19.6± 2.1% in S/G2/M. Compared to
controls, DAPT-treated HUVEC, in which GJA4 expression is
signiﬁcantly reduced (Fig. 2d), exhibited a decreased proportion
of cells in G1, and an increased proportion of actively cells in
S/G2/M. However, constitutive re-expression of GJA4 abolished
these DAPT-mediated cell cycle effects (Fig. 4d), indicating that
NOTCH regulates cell cycle status via GJA4.
Fig. 3 GJA4 regulates vascular remodeling. a GJA4 expression was predominantly detected in the remodeling plexus at the R-M boundary, in addition to
expression in SMA-invested arteries. (Colors: PECAM1 (red), SMA (cyan), GJA4 (green); scale bar: 250 µm (lower magniﬁcation), 100 µm (higher
magniﬁcation); symbols: a= artery, v= vein). b At higher magniﬁcation, GJA4 expression was observed in vessels beyond the R-M boundary, including in
large vessels not invested with SMA, as well as in adjacent smaller vessels. (Colors: PECAM1 (red), SMA (cyan), GJA4 (green); Scale bar= 50 µm; Symbols:
a= artery). c GJA4 was absent from tip cells at the vascular edge. (Colors: PECAM1 (red), GJA4 (green); Scale bar= 50 µm). d In P6 retinas lacking GJA4
(Gja4−/−) or NOTCH (WT + DAPT, or Notch1iECKO−Cre+), the developing vasculature was hyperdense in comparison to wild-type (Gja4+/+) tissues.
(Colors: IB4 (red); scale bar= 100 µm; symbols: a= artery, v= vein). e Expression of NOTCH target genes HES1, HEY1, and HEY2 were signiﬁcantly reduced
in FACS-sorted endothelial cells (PECAM1+/PTPRC−, commonly CD31+/CD45–) with DAPT treatment (mean relative mRNA expression± SEM vs. vehicle-
treated controls; n= 4 for all groups; paired Students’ t-test: p= 0.0002 (Hes1), p= 0.04 (Hey1), p= 0.047 (Hey2)). f Vessel (PECAM1+ or IB4+) area was
signiﬁcantly increased in NOTCH-inhibited (WT + DAPT or Notch1iECKO−Cre+) and GJA4-deleted (Gja4−/−) mice compared to associated controls (mean %
vessel area per retina± SEM vs. control; n= 6 (WT + Veh, WT + DAPT), n= 3 (Notch1iECKO−Cre−), n= 11 (Notch1iECKO−Cre+), n= 4 (Gja4+/+), n= 10
(Gja4−/−); Students’ t-test: p= 0.001 (WT + Veh vs. WT + DAPT), p= 0.004 (Notch1iECKO−Cre− vs. Notch1iECKO−Cre+), p= 0.0006 (Gja4+/+ vs. Gja4−/−)).
g Branchpoint number was also signiﬁcantly increased in WT + DAPT, Notch1iECKO−Cre+, and Gja4−/− animals (mean % branchpoint number per
retina± SEM vs. control; n= 7 (WT +Veh), n= 9 (WT + DAPT), n= 3 (Notch1iECKO−Cre−), n= 11 (Notch1iECKO−Cre+), n= 4 (Gja4+/+), n= 9 (Gja4−/−)
Students’ t-test: p= 0.03 (WT + Veh vs. WT + DAPT), p= 0.049 (Notch1iECKO−Cre− vs. Notch1iECKO−Cre+), p= 0.002 (Gja4+/+ vs. Gja4−/−)). h GJA4
expression was signiﬁcantly reduced in remodeling vessels of DAPT-treated WT animals, as well as in Notch1iECKO−Cre+ animals. (Colors: PECAM1 (red),
GJA4 (white); scale bar= 50 µm; symbols: a= artery)
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%± SEM vs. WT (Gja4+/+); n= 6 (WT), n= 12 (WT + DAPT), n= 3 (Gja4−/−); individual values plotted where n< 5; one-way ANOVA: p= 0.005
(S/G2/M), asterisks indicate p< 0.05 in post hoc t-tests). b pH3+ endothelial cells were more numerous in remodeling vessels of WT + DAPT and
Gja4−/− P6 retinas, compared to controls, and mitotic endothelial cells were mostly found at the R-M boundary (Colors: IB4 (red), ERG (blue), pH3
(magenta); scale bar: 100 µm (low magniﬁcation), 50 µm (high magniﬁcation); symbols: a= artery, r= remodeling, m=mature; mean number of pH3+/ERG
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p= 0.005 (Gja4+/+ vs. Gja4−/−, 700–800 µm), p= 0.03 (Gja4+/+ vs. Gja4−/−, 900–1000 µm)). c The nuclei of endothelial cells in G1 were marked by
CDT1-mOrange in remodeling vessels of Cdt1-mOrange+;Gja4+/+ reporter mice. CDT1-mOrange signal in endothelial cells of remodeling vessels in Gja4−/−
reporter mice was greatly reduced, compared to WT controls. (Colors: IB4 (red), ERG (blue), pH3 (magenta), CDT1 (green); scale bar: 100 µm (low
magniﬁcation), 50 µm (high magniﬁcation); symbols: a= artery). d In HUVEC, DAPT decreased the proportion of cells in G1 and increased the proportion in
S/G2/M; constitutive GJA4 expression (via lenti-Gja4) abolished these cell cycle effects of DAPT (mean difference in cell cycle %± SEM vs. DMSO; n= 9
(DMSO), n= 7 (DAPT), n= 8 (DAPT+lenti-Gja4); one-way ANOVA: p=0.04 (G1), p=0.03 (S/G2/M), asterisks indicate p< 0.05 in post hoc t-tests)
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Fig. 5 GJA4 regulates endothelial cell cycle arrest via CDKN1B. a CDKN1BmRNA expression was signiﬁcantly reduced in Gja4−/− P6 retinal endothelial cells
(CD31+/CD45−) (mean relative mRNA expression± SEM vs. Gja4+/− littermate controls; n= 3 (Cdk4, Gja4−/−; Cdk6, Gja4−/− Ccne1, Gja4+/−; Ccne2,
Gja4+/−), n= 4 (Cdk4, Gja4+/−; Cdk6, Gja4+/−; Ccnb1; Cdkn1a, Gja4−/−), n= 5 (Ccne1, Gja4−/−), n= 6 (Ccne2, Gja4−/−; Cdkn1a, Gja4+/−; Ccnd1,
Gja4−/−), n= 8 (Cdk2; Tp53, Gja4−/−), n= 9 (Ccnd1, Gja4+/−; Cdkn1b; Tp53, Gja4−/−); individual values plotted where n< 5). b CDKN1B expression was
detected in Gja4+/+, but not Gja4−/−, endothelial cells of remodeling retinal vessels. (Colors: PECAM1 (red), CDKN1B (green); scale bar: 50 µm). c CDKN1B
protein was elevated in HUVEC by 16 h FSS, and this effect was abolished by si-GJA4 (mean densitometry± SEM vs. Static; n= 3 for all groups; one-way
ANOVA: p= 0.002, asterisks indicate p< 0.05 in post hoc t-test). Uncropped western blots presented in Supplementary Fig. 14A. d Constitutive GJA4
expression (lenti-Gja4) arrested endothelial cells in G1 and reduced actively cycling cells in S/G2/M, while si-CDKN1B had the opposite effect, regardless of
GJA4 expression (mean difference in cell cycle %± SEM vs. Control; n= 6; one-way ANOVA: p= 0.0002 (G1), p= 0.0003 (S/G2/M), asterisks indicate
p< 0.05 in post hoc t-test vs. si-Ctrl + lenti-Ctrl). e GJA4 knockdown (si-GJA4) reduced the proportion of endothelial cells in G1 and increased the
proportion in S/G2/M, and constitutive expression of CDKN1B (lenti-CDKN1B) had the opposite effect, regardless of GJA4 expression (mean difference in
cell cycle %± SEM vs. Control; n= 3 for all groups; one-way ANOVA: p= 0.002 (G0), p< 0.0001 (G1), p< 0.0001 (S/G2/M), asterisks indicate p< 0.05
in post hoc t-tests vs. si-Ctrl+ lenti-Ctrl). f CDKN1B phosphorylation at serine 10 (pCDKN1B (S10)) and total protein levels were reduced by si-GJA4 and
rescued with lenti-Gja4. Uncropped blots presented in Supplementary Fig. 14B. g MAPK/ERK signaling inhibition by 1 h treatment with 20 µM U0126, an
inhibitor of MEK1/2, blocked GJA4-dependent CDKN1B phosphorylation at serine 10 and reduced total CDKN1B protein levels. Uncropped blots presented
in Supplementary Fig. 14C
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GJA4 regulates cell cycle status via CDKN1B. Cell cycle pro-
gression is tightly regulated by cyclins and associated regulatory
proteins. To identify cell cycle regulators targeted by FSS-
activated NOTCH and GJA4, we examined our whole RNA-Seq
data sets to determine whether the expression of cell cycle
effectors were altered by FSS, and whether that expression was
further affected by DAPT. We found that several cell cycle reg-
ulators were altered by 6 h FSS (vs. 6 h Static) (Supplementary
Fig. 13A), including the cyclin-dependent kinase inhibitor
CDKN1B, which encodes for CDKN1B (commonly, p27), an
inhibitor of G1-S transition. CDKN1B expression was upregu-
lated by FSS, and was also signiﬁcantly downregulated by DAPT
under FSS (Supplementary Fig. 13B), indicating that shear-
induced CDKN1B was dependent upon NOTCH signaling.
To determine whether cell cycle effectors identiﬁed as both
FSS-activated and NOTCH-dependent were also regulated by
GJA4, we next assessed expression of candidate cell cycle effectors
in sorted Gja4−/− retinal endothelial cells (which we deﬁned as
events positive for PECAM1 (or, CD31) and negative for PTPRC
(or, CD45)). Expression of CDKN1B (as well as its regulatory
targets CDK4 and CCNE1) was signiﬁcantly reduced in Gja4−/−
retinal endothelial cells compared to Gja4+/− littermate controls
(Fig. 5a); we detected no differences in the expression of other
cycle effectors assessed. In WT (Gja4+/+) P6 mice, CDKN1B was
expressed in PECAM1-positive vessels of the remodeling plexus,
but not detected in the remodeling plexus of Gja4−/− P6 mice
(Fig. 5b). Furthermore, FSS-induced upregulation of CDKN1B
protein expression was abrogated in HUVEC when GJA4
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Fig. 6 FSS-NOTCH-GJA4-CDKN1B axis regulates arterial identity genes. a Disorganized or absent SMA investment was observed in Gja4−/− and
WT + DAPT mice, compared to WT controls. (Colors: PECAM1 (red), SMA (white); scale bar: 100 µm; symbols: a= artery, v= vein, R= remodeling,
M=mature). b Radial SMA investment of arteries, as well as c radial distance of GJA5 (Cx40) expression, were reduced in Gja4−/− and DAPT-treated
animals (mean radial distance as % of total vascular outgrowth± SEM vs WT; n= 3 (WT + DAPT; WT, GJA5), n= 4 (WT, SMA), n= 6 (Gja4−/−); one-way
ANOVA: p= 0.03 (SMA), p= 0.04 (GJA5); asterisks indicate p< 0.05 in post hoc t-tests vs. WT). d DLL4 activation of NOTCH signaling upregulated
EFNB2 (EphrinB2) and GJA5, and this effect was abolished with si-GJA4 or si-CDKN1B (mean relative mRNA expression± SEM vs. PBS; n= 3 (si-GJA4;
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p= 0.0005 (si-GJA4, GJA5), p< 0.0001 (si-CDKN1B, GJA5)). e NOTCH activation was maximal with 1 h exposure to 18 dynes/cm2 shear (mean NICD
R.F.U.± SEM; n= 7000 cells, representative of N= 3). f Expression of GJA4 (Cx37), GJA5 (Cx40) and EFNB2 (EphrinB2) were also maximal at 18 dynes/
cm2 (mean relative mRNA expression± SE; n= 3, representative of 4 experiments). g Knockdown of NOTCH1, GJA4 or CDKN1B reduced basal and 10 h
FSS-induced upregulation of EFNB2 and GJA5 (mean relative mRNA expression± SEM vs. Static; n= 3 technical replicates; representative of two biological
replicates)
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expression was suppressed by si-GJA4 knockdown (Fig. 5c and
Supplementary Fig. 14A).
We next investigated whether CDKN1B was necessary for
GJA4 effects on endothelial cell cycle status. Control HUVEC
treated with empty lentivirus (lenti-Ctrl) and control siRNA (si-
Ctrl) had the following cell cycle distribution: 38.9± 0.02% in G0,
44.6± 0.02% in G1, and 16.9± 0.004% in S/G2/M. Constitutive
expression of GJA4 (via lenti-Gja4) increased the proportion of
cells in G1 and decreased the proportion of cells in S/G2/M
(Fig. 5d). In contrast, siRNA knockdown of CDKN1B (si-
CDKN1B, validated in Supplementary Fig. 12B, C) increased the
proportion of actively cycling cells in S/G2/M and decreased cells
in G1, regardless of GJA4 expression (Fig. 5d).
Similarly, HUVEC were transfected with si-GJA4 prior to
lentiviral delivery of human CDKN1B (lenti-CDKN1B, validated
in Supplementary Fig. 12D, E). The cell cycle distribution of
HUVEC transfected with si-Ctrl and infected with lenti-Ctrl was
like that of other control groups: 35.5± 1.3% in G0, 48.6± 1.0%
in G1, and 15.6± 0.5% in S/G2/M (Fig. 5e). GJA4 knockdown
(via si-GJA4) decreased the proportion of cells in G1 and
increased the S/G2/M fraction (Fig. 5e). Constitutive expression
of CDKN1B, whether in the presence or absence of GJA4, had the
pRB1
Untr DMSO Clot Palb
100
D
iff
er
en
ce
 in
ce
ll 
cy
cle
 %
 (v
s. 
DM
SO
)
R
el
at
iv
e 
m
R
N
A
e
xp
re
ss
io
n 
(vs
. D
MS
O)
D
iff
er
en
ce
 in
ce
ll 
cy
cle
 %
 (v
s. 
DM
SO
)
R
el
at
iv
e 
m
R
N
A
e
xp
re
ss
io
n 
(vs
. D
MS
O)
100
75
75
50
37
37
25
37
E2F1
CDK4
GJA4
CDKN1B
ACTB
RB1 (total)
60
45
30
15
10
5
0
Clotrimazole Clotrimazole
** *
*
*
*
*
Palbociclib
*
*
*
*
*
Palbociclib
*
*
*
*
G0
S/G2/M
G1
G0
S/G2/M
G1
EFNB2
EFNB2
GJA5
GJA5
GJA4
CDKN1B
CDKN1B
CDK4
20
0
–20
D
M
SO
D
M
SO
Cl
ot
 +
 s
i-C
DK
N1
B
Cl
ot
 +
 s
i-C
DK
N1
B
Cl
ot
Cl
ot
D
M
SO
Cl
ot
 +
 s
i-C
DK
N1
B
Cl
ot
D
M
SO
D
M
SO
Cl
ot
 +
 s
i-C
DK
N1
B
D
M
SO Pa
lb
D
M
SO Pa
lb
D
M
SO Pa
lb
D
M
SO Pa
lb
D
M
SO Pa
lb
D
M
SO Pa
lb
D
M
SO Pa
lb
D
M
SO Pa
lb
Cl
ot
 +
 s
i-C
DK
N1
B
Cl
ot
Cl
ot
D
M
SO
Cl
ot
 +
 s
i-C
DK
N1
B
Cl
ot
20
0
–20
3
2
1
0
Arterial
specification
signals
Arterial shear
Arterial identity
Cdt1-mOrange+
P6
 re
tin
a NOTCH
GJA4 (Cx37)
CDKN1B
(p27)
Cell cycle arrest
Remodeling plexus
IB4 ERG
pH3
CDT1
a v
a b c
d e
f g
Fig. 7 Endothelial cell cycle arrest, per se, enables arterial gene expression. a Treatment of HUVEC with 10 µM clotrimazole or 2 µM palbociclib reduced
RB1, phosphorylated RB1 (pRb1), and E2F1, suggestive of G1 arrest. Clotrimazole tended to upregulate CDKN1B expression and preserve GJA4 expression,
and CDK4 expression was lost only with CDK4/6i treatment. Uncropped blots presented in Supplementary Fig. 16. b Using FACS to assess cell cycle
distribution, clotrimazole was found to arrest HUVEC in G1, even when CDKN1B was knocked down (via si-CDKN1B) (mean difference in cell cycle %±
SEM vs. DMSO; n= 3 (Clotrimazole), n= 5 (DMSO), n= 6 (Clotrimazole+ si-CDKN1B); individual values plotted where n< 5; one-way ANOVA: p= 0.007
(G1), p= 0.03 (S/G2/M); asterisks indicate p< 0.05 in post hoc t-tests). c Clotrimazole upregulated EFNB2 and GJA5 regardless of CDKN1B expression
(mean relative mRNA expression± SEM vs. DMSO; n= 4 (Clotrimazole, p27), n= 5 (Clotrimazole, EFNB2; Clotrimazole, GJA5), n= 7 (Clotrimazole+ si-
CDKN1B), n= 8 (DMSO); individual values plotted where n< 5; one-way ANOVA: p= 0.03 (EFNB2, GJA5), p= 0.0007 (CDKN1B)). d Palbociclib treatment
also arrested endothelial cells in G1 (mean difference in cell cycle %± SEM vs. DMSO; n= 3 for all groups; Students’ t-test: p= 0.002 (G1), p< 0.0001 (S/
G2/M)), e upregulated EFNB2 and GJA5 (Cx40) mRNA levels, abolished CDK4 expression, and had no effect on GJA4 (Cx37) and CDKN1B (p27), (mean
relative mRNA expression± SEM vs DMSO; n= 9 (GJA4), n= 12 (EFNB2), n= 14 (GJA5), n= 16 (CDKN1B; CDK4); Students’ t-test: p= 0.02 (EFNB2, GJA5),
p< 0.0001 (CDK4)). f Endothelial cells within arteries and surrounding plexi of P6 retinas from Cdt1-mOrange+ reporter mice were predominantly in G1
phase, whereas endothelial cells in adjacent veins were not. (Colors: IB4 (red), ERG (blue), pH3 (magenta), CDT1 (green); scale bar: 100 µm). g We
hypothesize that in remodeling vessels, arterial shear activates a novel Notch-Cx37-p27 signaling pathway that promotes endothelial cell cycle arrest to
enable arterial gene expression
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opposite effect, increasing the proportion of cells arrested in
G0/G1 and decreasing the proportion of actively cycling S/G2/M
cells (Fig. 5e). Therefore, GJA4 regulates G1 arrest of endothelial
cells via CDKN1B.
MAPK/ERK signaling is required for GJA4 regulation of
CDKN1B. Although CDKN1B is transcriptionally regulated,
CDKN1B protein intracellular localization and function are pri-
marily inﬂuenced by its phosphorylation on serine and threonine
residues34. A signiﬁcant site of CDKN1B phosphorylation is
serine 10 (S10)35, which regulates nuclear export36 and protein
stability35,37. In cycling cells, serine 10 phosphorylation is asso-
ciated with CDKN1B ubiquitination and degradation to promote
G1/S transition, whereas in quiescent cells, phosphorylation at
serine 10 enhances protein stability to limit cell cycle progres-
sion37,38. We found that serine 10 phosphorylation (pCDKN1B
(S10)) was reduced after GJA4 knockdown (via si-GJA4) in
association with reduced total CDKN1B protein levels, which was
rescued by re-expression of GJA4 (Fig. 5f and Supplementary
Fig. 14B). These data suggest that GJA4 regulates CDKN1B sta-
bility and function and that this may involve serine 10 phos-
phorylation of CDKN1B protein.
Previous studies have shown that CDKN1B serine 10
phosphorylation is mediated by members of the MAPK family35.
The GJA4 C-terminus contains a high-probability MAPK target
consensus sequence39, and C-terminal truncation eliminates
GJA4 suppression of cancer cell proliferation40, suggesting
involvement of this site. To assess whether MAPK/ERK signaling
is required for Cx37-mediated phosphorylation and stabilization
of CDKN1B, we treated HUVEC for 1 h with 20 µM U0126, a
speciﬁc inhibitor of MEK1/2, which activates MAPK/ERK
signaling. U0126 blocked the capacity of re-expressed GJA4 to
preserve serine 10 phosphorylation and total CDKN1B protein
levels (Fig. 5g and Supplementary Fig. 14C). These results
demonstrate that GJA4 requires MAPK/ERK signaling to stabilize
CDKN1B protein.
Arterial development requires GJA4 and NOTCH. To deter-
mine the effects of remodeling plexus hyperproliferation (Fig. 4)
on vascular maturation, we assessed mural cell investment in
maturing arteries. In WT tissue, SMA labeling extends from the
center of the retina to the R-M boundary (Fig. 6a). By contrast,
SMA staining was markedly reduced or absent in DAPT-treated
WT retinas, as well as in Gja4−/− retinas. Quantiﬁcation of these
images showed ~ 20% decrease in the radial distance of SMA-
positive coverage in NOTCH-inhibited and Gja4−/− animals
(Fig. 6b), suggesting delayed arterial development. We further
observed a signiﬁcant decrease in the radial distance of GJA5
(commonly, Cx40) expression along the arteries of DAPT-treated
WT and Gja4−/− tissues (Fig. 6c), consistent with a defect in
acquisition of endothelial arterial identity.
FSS-induced NOTCH-GJA4 signaling regulates arterial iden-
tity. In our RNA-seq studies, we found that 6 h of FSS sig-
niﬁcantly increased the expression of arterial identity genes GJA5
and EFNB2 (commonly, EphrinB2). We next explored whether
GJA4 and CDKN1B function downstream of FSS-induced
NOTCH signaling to promote arterial identity. We found that
activation of NOTCH by DLL4 increased expression of EFNB2
(EphrinB2) (and GJA5) (Fig. 6d). However, knockdown of either
GJA4 (via si-GJA4) or CDKN1B (via si-CDKN1B) prevented
DLL4-induced upregulation of EFNB2, and signiﬁcantly reduced
GJA5 expression (Fig. 6d), indicating that GJA4 and CDKN1B
function downstream of NOTCH signaling to enable arterial gene
expression.
However, endothelial cells must be sensitive to the magnitude
of ﬂow during vascular morphogenesis in order to optimize
arterial-venous speciﬁcation and attain proper tissue perfusion3.
To test this, endothelial cell monolayers were exposed to 1 h of
shear over a wide physiological range of FSS magnitudes (0–50
dynes/cm2). NOTCH cleavage (Fig. 6e), GJA4 expression, and
expression of arterial genes EFNB2 and GJA5 (Fig. 6f) peaked at
intermediate FSS magnitudes typical of arteries, and was reduced
at magnitudes outside this range, demonstrating that arterial FSS
activates NOTCH-GJA4 signaling to enable arterial speciﬁcation.
Next, we used siRNA to knockdown NOTCH1, GJA4, and
CDKN1B under arterial FSS magnitudes (18 dynes/cm2) to
determine the contribution of NOTCH-GJA4-CDKN1B signaling
to shear-induced upregulation of arterial genes. NOTCH1, GJA4
and CDKN1B knockdown did not affect shear-activated KLF2
expression, indicating that mechanotransduction signaling com-
plexes were intact (Supplementary Fig. 15). Basal and FSS-
induced EFNB2 and GJA5 expression was reduced in all groups
compared to control cells, and GJA4 knockdown (via si-GJA4)
completely abolished FSS-induced upregulation of arterial
identity genes (Fig. 6g).
Endothelial G1 arrest is needed for arterial speciﬁcation. The
above results prompted us to hypothesize that FSS-activated
NOTCH-GJA4-CDKN1B signaling enables arterial speciﬁcation
via cell cycle arrest. However, as CDKN1B may also regulate
transcription independent of cell cycle effects34,41, we tested
whether cell cycle arrest, per se, mediates arterial gene expression.
HUVEC were treated with 10 μM clotrimazole, which causes G1
arrest via a CKN1B-independent mechanism42 (although it
modestly upregulates CDKN1B as a secondary effect), or with 2
µM palbociclib43, which speciﬁcally eliminates expression of
CDK4/6 without affecting CDKN1B or GJA4 expression (Fig. 7a
and Supplementary Fig. 16). Both drugs reduced total and
phosphorylated levels of RB1, as well as E2F1, consistent with
block of G1-to-S phase transition (Fig. 7a). Both drugs also
increased the proportion of endothelial cells in G1, decreased
endothelial cells in S/G2/M (Fig. 7b, d), and increased expression
of arterial markers EFNB2 and GJA5 (Fig. 7c, e). Knockdown of
CDKN1B had no effect on clotrimazole-induced G1 arrest
(Fig. 7b) or on the upregulation of arterial genes (Fig. 7c). Col-
lectively, these data indicate that G1 arrest enables arterial spe-
ciﬁcation. Consistent with this model, evaluation of Cdt1-
mOrange reporter mice revealed that endothelial cells in G1 are
more abundant in arterial endothelial cells and surrounding plexi
compared to veins (Fig. 7f).
Altogether, these data show that in remodeling endothelial
cells, arterial shear activates a novel NOTCH-GJA4-CDKN1B (or,
Notch-Cx37-p27) signaling pathway that promotes endothelial
cell cycle arrest to enable arterial speciﬁcation (Fig. 7g).
Discussion
During blood vessel remodeling, endothelial cell growth sup-
pression and arterial-venous speciﬁcation occur simultaneously,
but how these processes are regulated and coordinated was not
known. Herein, we demonstrate that endothelial G1 cell cycle
arrest is required for expression of arterial-speciﬁc genes. In
addition, FSS, speciﬁcally in the range typical of arterioles and
arteries, initiates growth arrest by activating NOTCH signaling,
which promotes endothelial cell cycle arrest via GJA4 and
downstream CDKN1B in remodeling vessels. These ﬁndings are
consistent with the observation that NOTCH signaling is low in
veins44, and that upregulation of venous endothelial gene
expression is not observed upon exposure to pulsatile blood ﬂow4.
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NOTCH signaling was previously thought to promote arterial
development primarily via upregulation of fate-speciﬁc genes
(reviewed in Marcelo et al.2). However, our ﬁndings suggest a
new paradigm in which the primary role of NOTCH signaling in
arterial-venous speciﬁcation is to modulate endothelial cell cycle
state, similar to the role of NOTCH in hemogenic endothelial cell
speciﬁcation16. How endothelial cell cycle arrest in G1 leads to
arterial speciﬁcation is unknown, but studies in embryonic stem
cells may offer a clue. Stem cells in different cell cycle phases
respond differently to inductive signals18. For example, early G1
arrest enables responses to factors that promote mesodermal or
endodermal vs. ectodermal commitment45,46. Arterial inductive
signals may therefore be similarly conﬁned to endothelial cells in
G1. Chromatin structure, epigenetic regulation, and accumulation
of transcription factors, cofactors, and miRNAs may all poten-
tially contribute to cell cycle-dependent sensitivity to extrinsic
cues.
The mechanism by which FSS at arterial magnitudes activates
NOTCH is unknown. That NOTCH is acutely activated at 1 h
following onset of shear makes transcriptional regulation
unlikely. Furthermore, although NOTCH signaling is innately
mechanosensitive47, the kinetics of NOTCH activation argue
against direct activation of NOTCH by ﬂuid shear forces. Instead,
ﬂuid shear stress-induced signal transduction could result in
altered membrane-cytoskeletal rearrangements, as is observed
within the CDH5 (VE-Cadherin)/PECAM1 (CD31) complex48
and mechanically induced NOTCH cleavage47. Alternatively,
shear signaling could modify stabilization and/or membrane
trafﬁcking of NOTCH and its ligands. Finally, shear-induced
alterations in membrane lipid composition might alter gamma-
secretase complex activity to indirectly enhance NOTCH
cleavage49. Thus, understanding activation of NOTCH by ﬂow
will require further investigation.
Also unknown is how GJA4, downstream of NOTCH, regulates
CDKN1B phosphorylation and possibly MAPK/ERK signaling. In
insulinoma cells, which typically do not express connexins,
enforced expression of GJA4 suppresses proliferation50 in a
manner that requires both gap junction channel function and the
C-terminal region of the protein, which is dispensible for gap
junction channel formation and instead mediates intracellular
signaling33,40. Interestingly, truncation of the GJA4 C-terminus
also eliminates a high-probability MAPK consensus site39 that
may be required, either alone and/or in combination with other
kinase target sites, for GJA4 to suppress cell growth. Further
studies of GJA4 function and interactions in endothelial cells will
be needed to address these questions.
Finally, although our studies were conducted in a develop-
mental setting, the FSS-NOTCH-GJA4-CDKN1B (or FSS-Notch-
Cx37-p27) pathway we characterize herein is likely also relevant
to vascular remodeling in adults. Mice deﬁcient in GJA420,32 or
CDKN1B51 display abnormal post-ischemic vessel growth and
remodeling. Flow-induced Notch-Cx37-p27 endothelial cell cycle
control is also likely to be important for maintenance and/or
repair of adult vasculature. Thus, Notch-Cx37-p27 signaling may
be an attractive candidate for treatment of vascular diseases, and
for promotion of proper vessel formation in tissue engineering
and regenerative medicine applications.
Methods
Cell culture. Primary human umbilical vein endothelial cells (HUVEC) were
obtained from the Yale core facility and only used up to passage 8. The cells were
cultured in M199 with 20% FBS (Gibco, Gemini), 100 µg/mL Heparin (Sigma), 50
µg/mL endothelial cell growth supplement (Sigma), and 1× penicillin/streptomycin
(Sigma); some received 10 μM DAPT (Sigma) or DMSO, or were seeded onto
surfaces pre-treated with 10 μg/mL recombinant human Dll4 (R&D). For siRNA
knockdown, cells pre-conditioned with EGM-2 (Lonza) for >16 h were transfected
with 20 nM si-GJA4 (Dharmacon L-011669-00), si-CDKN1B (Dharmacon L-
040178-00), si-NOTCH1 (Dharmacon L-007771-00), si-NOTCH4 (Dharmacon L-
011883-00) or control siRNA (Ambion AM4611) for >96 h. For lentiviral trans-
duction, HUVEC were pre-infected for 48 h with lentivirus containing mouse Gja4
(lenti-Gja4)33, human CDKN1B (lenti-CDKN1B, cloned from Addgene 14049) or
empty vector in presence of 10 μg/mL polybrene (Sigma). In MEK1/2 inhibitor
studies, cells were washed with fresh EGM-2 media overnight, and then treated for
1 h with 20 µM U0126 (Sigma) or DMSO. In cell cycle studies, cells were treated
with 24 h 10 μM clotrimazole (Sigma), 8 h 2 µM palbociclib (Sigma), or DMSO for
the equivalent period. Cell cultures were routinely tested for mycoplasma con-
tamination, and no positive test was obtained over the course of these studies.
Immunochemistry reagents. For Western blot: α-hGJA4 (Abcam ab181701 1 :
3000; or, Santa Cruz sc-27711 1 : 1000), α-CDKN1B (Cell Signaling 3686 1 : 3000;
or, Santa Cruz sc-527 1 : 1000), α-NOTCH-ICD (Cell Signaling 4147 s 1 : 3000),
α-RB1 (Cell Signaling 9309 1 : 3000), α-phosphorylated RB1 (Cell Signaling 9308
1 : 3000), α-E2F1 (Cell Signaling 3742 1 : 3000), α-CDK4 (Cell Signaling 12790 1 :
3000), α-TUBB (Tubulin) (Sigma-Aldrich T9026 1 : 3000), α-ACTB (β-Actin)
(Santa Cruz sc-1616, 1 : 500) and HRP-conjugated secondary antibodies (GE 1 :
5000). For immunocytochemistry: α-mGJA4 (Cx37) (Invitrogen 42-4500 1 : 300),
α-mGJA5 (Cx40) (Invitrogen 36-4900 1 : 300), α-phospho-HIST3 (pH3) (Upstate
06-570 1 : 300; or, Sigma H6409 1 : 300), α-pERK5 (EMD Millipore
07-507 1 : 200), α-CDKN1B (NeoMarkers MS-256-P1 1 : 100) α-mPECAM1 (R&D
AF3628 1 : 500), α-SMA (Dako M0851 1 : 300), α-ERG (Abcam ab92513 1 : 500),
Alexa488-conjugated isolectin B4 (IB4, Life Technologies 121411 1 : 300), and
ﬂuorescently conjugated secondary antibodies (Life Technologies 1 : 1000).
Shear. HUVEC were cultured on 25 × 55mm cell plastic slides pre-treated with 10
µg/mL ﬁbronectin. Slides were then either maintained static in a cell culture
incubator or mounted into parallel plate ﬂow chambers and subjected to 3–50
dynes/cm2 laminar shear for up to 24 h52. Flow was applied using a pressure-
dampened, gravity-driven dual reservoir system with media re-circulating via a
peristaltic pump (Masterﬂex, Cole Palmer). Media was maintained at 37 C, 5% CO2
using a Digi-sense temperature control system (Cole Palmer) and humidiﬁed
bubbler, respectively. Where indicated, cells were sheared in the presence of 10 µM
DAPT. For EdU assays, 10 µM EdU was added for 2 h under shear prior to
visualization (ThermoFisher Click-iT). Incorporation was quantiﬁed by imaging
eight random ﬁelds at low magniﬁcation and averaging the frequency of EdU-
positive nuclei vs. total nuclei. For some experiments, cleaved NOTCH receptor was
detected by immunocytochemistry (Cell Signaling) following shear, and ﬂuorescent
intensity was quantiﬁed for ~6500 cells per treatment group using Matlab.
RNA-Seq. HUVEC were exposed to shear (or static) conditions in triplicate, mRNA
was isolated (Qiagen, RNeasy Plus Micro Kit), and cDNA libraries were prepared
(ABM). Next-generation whole-transcriptome Illumina sequencing was performed
with the Yale Center for Genome Analysis. RNA-Seq reads from each sample were
aligned to human genome build 38 (GRCh38) using short reads aligner STAR53.
Gene expression quantiﬁcation was performed using RSEM54 with GENCODE
annotation (release 24: http://www.gencodegenes.org). Differential analysis was
performed using edgeR55 to identify genes with signiﬁcant expression changes
between groups (6 h Static vs. 6 h Shear; or 6 h Shear, Untreated vs. DAPT). Gene
transcripts observed to change signiﬁcantly (false discovery rate< 0.001) between
static and shear groups were used for functional enrichment analysis by running
GOseq56. A modiﬁed version of the nEASE algorithm57,58 was used to assess
functional enrichment of nested GOseq (nGO) terms. Brieﬂy, each enriched upper-
level GOseq (GO) term was then used for nGO analysis to identify statistically
enriched nGO terms driving upper-level functional enrichment of non-speciﬁc GO
terms. GO-nGO paired terms relating to cell proliferation, cell signaling and
development were selected for further consideration (Supplementary Data 1). Genes
in Supplementary Data 1 were searched against established Kegg signaling modules
(http://www.kegg.jp/kegg/tool/map_module.html); modules lacking upper-level
block hits were discarded to yield relevant ﬂow-sensitive signaling pathways.
Quantitative PCR. Transcriptomes were prepared from cultured HUVEC or
PECAM1+/PTPRC− (commonly, CD31+/CD45–) endothelial cells sorted from
digested retinas of Gja4−/− neonates (or Gja4+/− littermates) using ﬂow cytometry
(see below, typical yield: ~2000 cells). Resulting cDNA libraries were probed by
quantitative PCR (qPCR) using published qPCR primers (PrimerBank, sequences
listed in Supplementary Table 4).
Consensus sequence scanning. The mouse genomic promoter and coding sequence
for Gja4—deﬁned as −5 kb to +3 kb from the transcriptional start site of mouse Gja4
mRNA sequence (Genbank #NM_008120)—was identiﬁed from published C57Bl/6 J
GRCm38.p3 chromosome 4 assembly (positions 127311039–127319039, Genbank
#NC_00070.6). The human genomic promoter and coding sequence for GJA4 was also
identiﬁed (positions 34789196–34797196 of GrCh38.p2 chromosome 1, with Genbank
#NM_002060.2 as reference). Both sequences were scanned with DMINDA software59
to identify high-probability (p< 0.001) matches to the RBP-Jκ consensus motif (C/T)
(C/G)TG(G/A)GA(A/G/T)60,61.
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ChIP. Chromatin-immunoprecipitation studies were performed according to
manufacturer’s speciﬁcations (R&D ECP001) using α-RBP-Jκ (Santa Cruz sc-
28713X 2.5 µg/mL) (or equivalent concentration of IgG control, Santa Cruz sc-
2027X), biotinylated α-Rabbit (Vector BA-100 2.5 µg/mL) and streptavidin-
conjugated agarose beads (Sigma 85881-1 mL). Resulting samples were probed with
primers (Supplementary Table 4) targeting sequence ﬂanking the human GJA4
transcriptional start site.
Animals. All animals were on a C57Bl/6 background, and all studies were con-
ducted in compliance with Yale’s Institutional Animal Care and Usage Committee
guidelines. Male and female Gja4−/− animals62 were compared to wild-type Gja4+/+
or Gja4+/− littermates or age-matched wild-type C57Bl/6 animals (Jackson
#025697), as indicated. Gja4−/− were also crossed with mice bearing a Cdt1-
mOrange fusion protein54 (gift of S. Guo) to generate Cdt1-mOrange+;Gja4−/−
mice (or Cdt1-mOrange+ ;Gja4+/+ littermate controls). Some wild-type animals
received two subcutaneous injections of 100 mg/kg DAPT (or drug vehicle) at 24 h
and 12 h prior to killing; in these studies, littermates were randomized with regard
to whether they receive drug or vehicle control. Notch1iECKO animals were gen-
erated by crossing Notch1ﬂox/ﬂox (Jackson #006951) mice with Cdh5CreERt2 mice,
which express a tamoxifen-inducible Cre recombinase in endothelial cells driven by
a CDH5 (VE-Cadherin) promoter. NOTCH1 was post-natally deleted in endo-
thelial cells by injection of 100 mg/kg tamoxifen (Sigma) at P1-3, prior to animal
killing at P6; Cre+ NOTCH-deleted animals were compared against Cre− litter-
mate controls.
Intracardiac injection. Freshly killed P6 animals received a 500 μL bolus of 10 mg/
mL lysine-ﬁxable ﬂuorescently conjugated 70 kDa rhodamine dextran (Thermo-
Fisher) into the left ventricle. Eyes were removed and ﬁxed in 4% formaldeyhyde
for 18 min before retinal dissection and immunohistochemistry, as described
above.
Retinal vascular analysis. Neonatal mouse retinas (P3-21) were collected and
stained as previously described12,25–27. In brief, eyes were pre-ﬁxed in 4% paraf-
ormaldehyde and dissected retinas were post-ﬁxed for 5 min in 4% paraf-
ormaldehyde at room temperature or for 20 min in 100% methanol at −20 °C.
Retinas were incubated in blocking solution (3% BSA, 0.25% Triton-X in PBS) and
incubated overnight in staining solution (1% BSA, 0.25% Triton-X in PBS) con-
taining primary antibodies (listed above). Following PBS wash, retinas were
incubated for 1 h at room temperature in staining solution containing secondary
antibody (listed above); if staining with ﬂuorescently conjugated IB4, staining
solution is supplemented with 100 mg/mL CaCl2 and MgCl2. Retinas were then
washed and mounted on glass slides for confocal imaging. The remodeling region
was delineated as the distance between the vascular edge and the point where SMA
signal is indistinguishable from background (ImageJ). GJA5 and SMA expression
was calculated as the radial distance from the retinal center to the point at which
ﬂuorescent signal for each marker was undetectable. From a 769μm2 × 923μm2
ROI of the remodeling region, total vascular (i.e., PECAM1+ or IB4+) area
(ImageJ) and plexus (Retina Analyser v.2, Centre de Morphologie Mathematique,
École Nationale Superieure des Mines de Paris) and arterial (ImageJ) branchpoint
number were calculated. Linear distance from vascular edge was measured in whole
retinal quadrants for mitotic endothelial cells (pH3+/ERG+). Endothelial cells in
G1 were identiﬁed in Cdt1-mOrange+ reporter mice as CDT1+/ERG+ cells. For all
studies involving retinal vascular morphometric analysis, the investigator was
blinded to animal genotype until imaging processing was complete.
Flow cytometry. Age-matched Gja4−/− and Gja4+/+ retinas were freshly dissected
and digested in 1 mg/mL collagenase type II for 20 min in DMEM (Gibco) with
20% FBS (Gibco or Gemini) to obtain single-cell suspensions. Alternatively,
HUVEC were lifted using 0.25% trypsin and resuspended in PBS. Cells were
resuspended in 100 μL staining medium (HBSS with 10% FBS, 20 mM HEPES and
1mg/mL D-glucose), and incubated for 15 min in 10 μg/mL Hoechst 33342 (Sigma)
at 37 °C, and for 15 min with 0.5 μg/mL Pyronin Y (Sigma P9172) and/or ﬂuor-
escently conjugated antibodies (α-mPECAM1-APC, BD Pharmingen 551262 1 :
100; α-mPTPRC-FITC, BD Pharmingen 553088 1 : 100). Washed pellets were
resuspended in 0.1% FBS in PBS. Endothelial cells were identiﬁed as PECAM1
+/PTPRC− (commonly, CD31+/CD45–) events and cell cycle analysis was per-
formed by comparison of DNA (Hoechst) and RNA (Pyronin Y) content for each
event.
Statistics. Power analysis was performed on retinal vascular morphometry data
collected from WT + DAPT (vs. WT + Vehicle) P6 tissue, since NOTCH inhibition
is known to induce a hyperdensity phenotype in P6 retinas. Power analysis was also
performed on cell cycle data from sorted retinal endothelial cells fromWT + DAPT
(vs. WT + Vehicle) to assess the statistical effect size of cell cycle distribution
changes associated with vascular hyperdensity. Power analysis was also performed
on HUVEC treated with 2 µM palbociclib (vs. DMSO), which has been shown to
induce G1 arrest. Finally, power analysis was performed on HES1mRNA transcript
levels in HUVEC treated with 10 µM DAPT (vs. DMSO) or 10 μg/mL DLL4 (vs.
PBS), which is known to impact transcription of canonical NOTCH targets. In all
cases, a minimum sample size of 3 was shown to be sufﬁcient to detect signiﬁcant
differences at a power of 0.80 and α= 0.05, although pilot data also suggested that a
sample size of 5 or greater was preferable. Therefore, for all experiments, we
constrained sample size to a minimum of 3–5 with a maximum sampling ratio of 4.
Analysis of data obtained through these pilot studies revealed that data were
normally distributed and that variance was similar between sample and control
groups.
For animal studies, in rare cases, pups were a priori discarded if they appeared
to be underweight or lethargic at the time of study onset, but no animals were post
hoc excluded from the data set. In rare cases, single data points obtained by qPCR
were considered outliers and excluded from subsequent analysis if they fell >2 SD
from the sample mean.
Unless otherwise indicated, statistics (α= 0.05) were performed using either a
standard two-tail Student’s t-test, or a two-way ANOVA test, followed by post hoc
t-test with Bonferroni correction.
Code availability. Matlab code and other relevant data associated with these
studies are available upon reasonable.
Data availability. The RNA-Seq data sets generated and analyzed in the current
study are available at the NCBI Sequence Read Archive (Accession Number:
#SRP113256).
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